Evaluation of the Fill-it-up-design to use historical control data in randomized clinical trials with two arm parallel group design

被引:0
|
作者
Wied, Stephanie [1 ]
Posch, Martin [2 ]
Hilgers, Ralf-Dieter [1 ]
机构
[1] Rhein Westfal TH Aachen, Inst Med Stat, Aachen, Germany
[2] Med Univ Vienna, Inst Med Stat, Ctr Med Data Sci, Vienna, Austria
关键词
Randomized clinical trial; Historical control; External controls; Type I error probability; Power; Sample size; Equivalence; INFORMATION; POWER; PRIORS;
D O I
10.1186/s12874-024-02306-2
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
PurposeIn the context of clinical research, there is an increasing need for new study designs that help to incorporate already available data. With the help of historical controls, the existing information can be utilized to support the new study design, but of course, inclusion also carries the risk of bias in the study results.MethodsTo combine historical and randomized controls we investigate the Fill-it-up-design, which in the first step checks the comparability of the historical and randomized controls performing an equivalence pre-test. If equivalence is confirmed, the historical control data will be included in the new RCT. If equivalence cannot be confirmed, the historical controls will not be considered at all and the randomization of the original study will be extended. We are investigating the performance of this study design in terms of type I error rate and power.ResultsWe demonstrate how many patients need to be recruited in each of the two steps in the Fill-it-up-design and show that the family wise error rate of the design is kept at 5%\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\%$$\end{document}. The maximum sample size of the Fill-it-up-design is larger than that of the single-stage design without historical controls and increases as the heterogeneity between the historical controls and the concurrent controls increases.ConclusionThe two-stage Fill-it-up-design represents a frequentist method for including historical control data for various study designs. As the maximum sample size of the design is larger, a robust prior belief is essential for its use. The design should therefore be seen as a way out in exceptional situations where a hybrid design is considered necessary.
引用
收藏
页数:16
相关论文
共 30 条
  • [21] Matching design for augmenting the control arm of a randomized controlled trial using real-world data
    Liu, Yingying
    Lu, Bo
    Foster, Richard
    Zhang, Yiwei
    Zhong, Z. John
    Chen, Ming-Hui
    Sun, Peng
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2022, 32 (01) : 124 - 140
  • [22] A covariate-adjusted adaptive design for two-stage clinical trials with survival data
    Bandyopadhyay, Uttam
    Biswas, Atanu
    Bhattacharya, Rahul
    STATISTICA NEERLANDICA, 2010, 64 (02) : 202 - 226
  • [23] A two-stage drop-the-losers design for time-to-event outcome using a historical control arm
    Abbas, Rachid
    Wason, James
    Michiels, Stefan
    Le Teuff, Gwenael
    PHARMACEUTICAL STATISTICS, 2022, 21 (01) : 268 - 288
  • [24] Critical appraisal of arguments for the delayed-start design proposed as alternative to the parallel-group randomized clinical trial design in the field of rare disease
    Loukia M. Spineli
    Eva Jenz
    Anika Großhennig
    Armin Koch
    Orphanet Journal of Rare Diseases, 12
  • [25] Critical appraisal of arguments for the delayed-start design proposed as alternative to the parallel-group randomized clinical trial design in the field of rare disease
    Spineli, Loukia M.
    Jenz, Eva
    Grosshenning, Anika
    Koch, Armin
    ORPHANET JOURNAL OF RARE DISEASES, 2017, 12
  • [26] A roadmap to using historical controls in clinical trials – by Drug Information Association Adaptive Design Scientific Working Group (DIA-ADSWG)
    Mercedeh Ghadessi
    Rui Tang
    Joey Zhou
    Rong Liu
    Chenkun Wang
    Kiichiro Toyoizumi
    Chaoqun Mei
    Lixia Zhang
    C. Q. Deng
    Robert A. Beckman
    Orphanet Journal of Rare Diseases, 15
  • [27] A roadmap to using historical controls in clinical trials - by Drug Information Association Adaptive Design Scientific Working Group (DIA-ADSWG)
    Ghadessi, Mercedeh
    Tang, Rui
    Zhou, Joey
    Liu, Rong
    Wang, Chenkun
    Toyoizumi, Kiichiro
    Mei, Chaoqun
    Zhang, Lixia
    Deng, C. Q.
    Beckman, Robert A.
    ORPHANET JOURNAL OF RARE DISEASES, 2020, 15 (01)
  • [28] Sample size determinations for group-based randomized clinical trials with different levels of data hierarchy between experimental and control arms
    Heo, Moonseong
    Litwin, Alain H.
    Blackstock, Oni
    Kim, Namhee
    Arnsten, Julia H.
    STATISTICAL METHODS IN MEDICAL RESEARCH, 2017, 26 (01) : 399 - 413
  • [29] On Simon's two-stage design for single-arm phase IIA cancer clinical trials under Beta-binomial distribution
    Liu, Junfeng
    Lin, Yong
    Shih, Weichung Joe
    STATISTICS IN MEDICINE, 2010, 29 (10) : 1084 - 1095
  • [30] A novel equivalence probability weighted power prior for using historical control data in an adaptive clinical trial design: A comparison to standard methods
    Bennett, Maxine
    White, Simon
    Best, Nicky
    Mander, Adrian
    PHARMACEUTICAL STATISTICS, 2021, 20 (03) : 462 - 484